Sephmer Sciences
Making A Difference in Clinical Research
Many physicians are interested in learning more about clinical research and even having their site participate in a clinical trial. But very few doctors know where to turn and how to begin that process.
Our focus on clinical trials which offfers small, mid-size, and large multi-national companies the opportunity to conduct global clinical trials. We have strategically built an infrastructure, methodology and global network (CONNECT Consortium) to give you access around the world to sites and research subjects.Our business model focuses on Phase I-III clinical trials, including:
- First-In-Human Studies
- Dose Escalation
- Bioavailability / Bioequivalence
- Pharmacokinetic / Pharmacodynamic (PK/PD)
- Drug-Drug Interaction
- Vaccine Development
- Novel Delivery Systems
- Radio Labeling / Mass Balance
- Challenge Studies
- Proof of Concept
Our staff's experience in clinical trials encompasses a broad spectrum of therapeutic areas, including:
- CNS
- Women's Health
- Infectious Disease
- Immunology
- Cardiovascular
- Metabolic Disease
- Ophthalmology
- Urology
- Nephrology
Sephmer has formed the Research Investigator Institute and trained physicians and hospital administrator from across the country including the east coast to the mid west (from the south - Kentucky to Minnesota) and Bangalore, India. Our mission is to train more community physicians, nurses, clinicians, and hospital administrators than any other company because we want to get investigators prepared to take advantage of the growing opportunities in research.
Sephmer Advantage
Sephmer is a company dedicated to increasing the number of trained investigators and helping them through the clinical trials process.
